Sign up to save your podcasts
Or
Share BTK Inhibitors in Multiple Sclerosis Treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BTK Inhibitors in Multiple Sclerosis Treatment
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
279279 ratings
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
133 Listeners
NEJM This Week
314 Listeners
Practical Neurology Podcast
48 Listeners
JAMA Clinical Reviews
492 Listeners
The Curbsiders Internal Medicine Podcast
3,325 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,116 Listeners
Neurology Today in 5
24 Listeners
Annals On Call Podcast
191 Listeners
The Clinical Problem Solvers
513 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Neurology Exam Prep Podcast
183 Listeners
The Curious Clinicians
365 Listeners
Continuum Audio
79 Listeners